Back to search results

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

Abroad (travel likely)Recruiting

Conditions

Growth Hormone Deficiency

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Ascendis Investigational Site, Phoenix, Arizona, United States

  • Ascendis Investigational Site, Orange, California, United States

  • Ascendis Investigational Site, Sacramento, California, United States

  • Ascendis Investigational Site, San Francisco, California, United States

  • Ascendis Pharma Investigational Site, Centennial, Colorado, United States

  • Ascendis Investigational Site, Washington D.C., District of Columbia, United States

  • Ascendis Investigational Site, Orlando, Florida, United States

  • Ascendis Investigational Site, Orlando, Florida, United States

  • Ascendis Investigational Site, Tampa, Florida, United States

  • Ascendis Investigational Site, Sandy Springs, Georgia, United States

  • Ascendis Investigational Site, Boise, Idaho, United States

  • Ascendis Investigational Site, Indianapolis, Indiana, United States

  • Ascendis Investigational Site, Iowa City, Iowa, United States

  • Ascendis Investigational Site, Louisville, Kentucky, United States

  • Ascendis Investigational Site, Minneapolis, Minnesota, United States

  • Ascendis Investigational Site, Las Vegas, Nevada, United States

  • Ascendis Investigational Site, Lebanon, New Hampshire, United States

  • Ascendis Investigational Site, Manchester, New Hampshire, United States

  • Ascendis Investigational Site, Morristown, New Jersey, United States

  • Ascendis Investigational Site, New Hyde Park, New York, United States

  • Ascendis Investigational Site, Cincinnati, Ohio, United States

  • Ascendis Investigational Site, Portland, Oregon, United States

  • Ascendis Investigational Site, Columbia, South Carolina, United States

  • Ascendis Investigational Site, Dallas, Texas, United States

  • Ascendis Investigational Site, El Paso, Texas, United States

  • Ascendis Investigational Site, Norfolk, Virginia, United States

  • Ascendis Investigational Site, Seattle, Washington, United States

Study leads

  • Medical Director, MD

    Study Director

    Ascendis Pharma A/S

View source on ClinicalTrials.gov(opens in a new tab)